Key facts
- It has raised $500K; the latest was Early Stage VC in Jun 2025.
- Notable investors include Y Combinator, Mana Ventures, Rebel Fund, The Impact Venture.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Aegis (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Aegis (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aegis (Healthcare Technology Systems)
Developer of healthcare revenue recovery software designed for automating insurance denial appeals. The company's platform utilizes artificial intelligence (AI) to identify denied claims, generate policy-specific appeal letters using clinical and claims data, and track the appeal process end-to-end with integrated analytics and real-time collaboration tools, enabling healthcare providers to recover lost revenue more efficiently and with less administrative burden.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 4
- Website
- aegishealth.us/
- Ownership
- Privately Held (backing)
Aegis (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aegis (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aegis (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.